Cargando…

Ligand-based quantitative structural assessments of SARS-CoV-2 3CL(pro) inhibitors: An analysis in light of structure-based multi-molecular modeling evidences

Due to COVID-19, the whole world is undergoing a devastating situation, but treatment with no such drug candidates still has been established exclusively. In that context, 69 diverse chemicals with potential SARS-CoV-2 3CL(pro) inhibitory property were taken into consideration for building different...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adhikari, Nilanjan, Banerjee, Suvankar, Baidya, Sandip Kumar, Ghosh, Balaram, Jha, Tarun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627846/ https://www.ncbi.nlm.nih.gov/pubmed/34866654 http://dx.doi.org/10.1016/j.molstruc.2021.132041

Ejemplares similares

Glycyrrhizin as a promising kryptonite against SARS-CoV-2: Clinical, experimental, and theoretical evidences
por: Banerjee, Suvankar, et al.
Publicado: (2023)

Structural Insight Into the Viral 3C-Like Protease Inhibitors: Comparative SAR/QSAR Approaches
por: Adhikari, Nilanjan, et al.
Publicado: (2017)

Identification of potential binders of the main protease 3CL(pro) of the COVID-19 via structure-based ligand design and molecular modeling
por: Macchiagodena, Marina, et al.
Publicado: (2020)

Structure-based virtual screening against SARS-3CL(pro) to identify novel non-peptidic hits
por: Mukherjee, Prasenjit, et al.
Publicado: (2008)

Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors
por: Amin, Sk. Abdul, et al.
Publicado: (2021)

First structure–activity relationship analysis of SARS-CoV-2 virus main protease (Mpro) inhibitors: an endeavor on COVID-19 drug discovery
por: Amin, Sk. Abdul, et al.
Publicado: (2021)

Dual targeting of 3CL(pro) and PL(pro) of SARS-CoV-2: A novel structure-based design approach to treat COVID-19
por: Rajpoot, Sajjan, et al.
Publicado: (2020)

Potential Broad Spectrum Inhibitors of the Coronavirus 3CL(pro): A Virtual Screening and Structure-Based Drug Design Study
por: Berry, Michael, et al.
Publicado: (2015)

MetalProGNet: a structure-based deep graph model for metalloprotein–ligand interaction predictions
por: Jiang, Dejun, et al.
Publicado: (2023)

Integration of Ligand-Based and Structure-Based Methods for the Design of Small-Molecule TLR7 Antagonists
por: Pal, Sourav, et al.
Publicado: (2022)

Engineering a novel endopeptidase based on SARS 3CL(pro)
por: Kuo, Chih-Jung, et al.
Publicado: (2009)

Targeting novel structural and functional features of coronavirus protease nsp5 (3CL(pro), M(pro)) in the age of COVID-19
por: Roe, Molly K., et al.
Publicado: (2021)

Protease targeted COVID-19 drug discovery: What we have learned from the past SARS-CoV inhibitors?
por: Amin, Sk Abdul, et al.
Publicado: (2021)

Ligand placement based on prior structures: the guided ligand-replacement method
por: Klei, Herbert E., et al.
Publicado: (2013)

Crystallographic models of SARS-CoV-2 3CL(pro): in-depth assessment of structure quality and validation
por: Jaskolski, Mariusz, et al.
Publicado: (2021)

An overview of potential inhibitors targeting non-structural proteins 3 (PL(pro) and Mac1) and 5 (3CL(pro)/M(pro)) of SARS-CoV-2
por: Yan, Fangfang, et al.
Publicado: (2021)

Multi-parameter scoring functions for ligand- and structure-based de novo design
por: Bös, Fabian, et al.
Publicado: (2010)

In Silico Design of New Dual Inhibitors of SARS-CoV-2 M(PRO) through Ligand- and Structure-Based Methods
por: Bono, Alessia, et al.
Publicado: (2023)

Prediction of Protein–ligand Interaction Based on Sequence Similarity and Ligand Structural Features
por: Karasev, Dmitry, et al.
Publicado: (2020)

Unmasking of crucial structural fragments for coronavirus protease inhibitors and its implications in COVID-19 drug discovery
por: Ghosh, Kalyan, et al.
Publicado: (2021)

Structurally Similar Triphenylphosphine-Stabilized Undecagolds, Au(11)(PPh(3))(7)Cl(3) and [Au(11)(PPh(3))(8)Cl(2)]Cl, Exhibit Distinct Ligand Exchange Pathways with Glutathione
por: McKenzie, Lallie C., et al.
Publicado: (2014)

Synergistic approach of structure-based and ligand-based drug design for the development of selective cannabinod receptor ligands
por: Günther, Robert, et al.
Publicado: (2012)

Ligand-based and structure-based design of novel histone demethylase inhibitors
por: Carlino, Luca, et al.
Publicado: (2013)

PDB-Ligand: a ligand database based on PDB for the automated and customized classification of ligand-binding structures
por: Shin, Jae-Min, et al.
Publicado: (2005)

Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CL(pro)): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS
por: Tomar, Sakshi, et al.
Publicado: (2015)

Complete Description of the LaCl(3)–NaCl Melt Structure and the Concept of a Spacer Salt That Causes Structural Heterogeneity
por: Emerson, Matthew S., et al.
Publicado: (2022)

Synthesis, Structure and Biological Activity of Indole–Imidazole Complexes with ZnCl(2): Can Coordination Enhance the Functionality of Bioactive Ligands?
por: Babijczuk, Karolina, et al.
Publicado: (2023)

Structure-Based Evolution of Subtype-Selective Neurotensin Receptor Ligands
por: Schaab, Carolin, et al.
Publicado: (2014)

Identification of Novel Smoothened Ligands Using Structure-Based Docking
por: Lacroix, Celine, et al.
Publicado: (2016)

Editorial: Chemoinformatics Approaches to Structure- and Ligand-Based Drug Design
por: Ferreira, Leonardo L. G., et al.
Publicado: (2018)

Best of Both Worlds: On the Complementarity of Ligand-Based and Structure-Based Virtual Screening
por: Broccatelli, Fabio, et al.
Publicado: (2014)

Insilico generation of novel ligands for the inhibition of SARS-CoV-2 main protease (3CL(pro)) using deep learning
por: Prabhakaran, Prejwal, et al.
Publicado: (2023)

Community-based rehabilitation for physically impaired earthquake victims: An evidence-based practice protocol and its pre–post experimental study
por: Adhikari, Shambhu P., et al.
Publicado: (2018)

Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants
por: Tahir ul Qamar, Muhammad, et al.
Publicado: (2020)

Structure of the human ClC-1 chloride channel
por: Wang, Kaituo, et al.
Publicado: (2019)

Crystal structure of a mononuclear Ru(II) complex with a back-to-back terpyridine ligand: [RuCl(bpy)(tpy–tpy)](+)
por: Rein, Francisca N., et al.
Publicado: (2015)

Crystal structures of three mercury(II) complexes [HgCl(2) L] where L is a bidentate chiral imine ligand
por: Hernández, Guadalupe, et al.
Publicado: (2015)

Ligands in PSI structures
por: Kumar, Abhinav, et al.
Publicado: (2010)

Quantitative structure–activity relationship-based computational approaches
por: Bastikar, Virupaksha, et al.
Publicado: (2022)

Discovery of SARS-CoV-2 3CL(Pro) Peptidomimetic Inhibitors through the Catalytic Dyad Histidine-Specific Protein–Ligand Interactions
por: Wang, Yaxin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_llj4bo1gtmkg818sjpk4cqe06e